View in EDS HTML Full Text PDF Full Text

Clinical research progress on β-cell dysfunction in T2DM development in the Chinese population.

Saved in:
Bibliographic Details
Title: Clinical research progress on β-cell dysfunction in T2DM development in the Chinese population.
Authors: Chen Y; State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100050, China.; Diabetes Research Center of Chinese Academy of Medical Sciences, Beijing, 100050, China.; CAMS Key Laboratory of Molecular Mechanism and Target Discovery of Metabolic Disorder and Tumorigenesis, Beijing, 100050, China., Jiang Q; State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100050, China.; Diabetes Research Center of Chinese Academy of Medical Sciences, Beijing, 100050, China.; CAMS Key Laboratory of Molecular Mechanism and Target Discovery of Metabolic Disorder and Tumorigenesis, Beijing, 100050, China., Xing X; State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100050, China.; Diabetes Research Center of Chinese Academy of Medical Sciences, Beijing, 100050, China.; CAMS Key Laboratory of Molecular Mechanism and Target Discovery of Metabolic Disorder and Tumorigenesis, Beijing, 100050, China., Yuan T; Department of Endocrinology, Key Laboratory of Endocrinology of Ministry of Health, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China. t75y@sina.com., Li P; State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100050, China. lipp@imm.ac.cn.; Diabetes Research Center of Chinese Academy of Medical Sciences, Beijing, 100050, China. lipp@imm.ac.cn.; CAMS Key Laboratory of Molecular Mechanism and Target Discovery of Metabolic Disorder and Tumorigenesis, Beijing, 100050, China. lipp@imm.ac.cn.
Source: Reviews in endocrine & metabolic disorders [Rev Endocr Metab Disord] 2025 Feb; Vol. 26 (1), pp. 31-53. Date of Electronic Publication: 2024 Oct 09.
Publication Type: Journal Article; Review; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Springer Country of Publication: Germany NLM ID: 100940588 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-2606 (Electronic) Linking ISSN: 13899155 NLM ISO Abbreviation: Rev Endocr Metab Disord Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39382753
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Clinical research progress on β-cell dysfunction in T2DM development in the Chinese population.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Chen+Y%22">Chen Y</searchLink>; State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100050, China.; Diabetes Research Center of Chinese Academy of Medical Sciences, Beijing, 100050, China.; CAMS Key Laboratory of Molecular Mechanism and Target Discovery of Metabolic Disorder and Tumorigenesis, Beijing, 100050, China.<br /><searchLink fieldCode="AU" term="%22Jiang+Q%22">Jiang Q</searchLink>; State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100050, China.; Diabetes Research Center of Chinese Academy of Medical Sciences, Beijing, 100050, China.; CAMS Key Laboratory of Molecular Mechanism and Target Discovery of Metabolic Disorder and Tumorigenesis, Beijing, 100050, China.<br /><searchLink fieldCode="AU" term="%22Xing+X%22">Xing X</searchLink>; State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100050, China.; Diabetes Research Center of Chinese Academy of Medical Sciences, Beijing, 100050, China.; CAMS Key Laboratory of Molecular Mechanism and Target Discovery of Metabolic Disorder and Tumorigenesis, Beijing, 100050, China.<br /><searchLink fieldCode="AU" term="%22Yuan+T%22">Yuan T</searchLink>; Department of Endocrinology, Key Laboratory of Endocrinology of Ministry of Health, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China. t75y@sina.com.<br /><searchLink fieldCode="AU" term="%22Li+P%22">Li P</searchLink>; State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100050, China. lipp@imm.ac.cn.; Diabetes Research Center of Chinese Academy of Medical Sciences, Beijing, 100050, China. lipp@imm.ac.cn.; CAMS Key Laboratory of Molecular Mechanism and Target Discovery of Metabolic Disorder and Tumorigenesis, Beijing, 100050, China. lipp@imm.ac.cn.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100940588%22">Reviews in endocrine & metabolic disorders</searchLink> [Rev Endocr Metab Disord] 2025 Feb; Vol. 26 (1), pp. 31-53. <i>Date of Electronic Publication: </i>2024 Oct 09.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer%22">Springer </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>100940588 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1573-2606 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2213899155%22">13899155 </searchLink><i>NLM ISO Abbreviation: </i>Rev Endocr Metab Disord <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39382753
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s11154-024-09914-9
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 31
    Titles:
      – TitleFull: Clinical research progress on β-cell dysfunction in T2DM development in the Chinese population.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Chen Y
      – PersonEntity:
          Name:
            NameFull: Jiang Q
      – PersonEntity:
          Name:
            NameFull: Xing X
      – PersonEntity:
          Name:
            NameFull: Yuan T
      – PersonEntity:
          Name:
            NameFull: Li P
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 02
              Text: 2025 Feb
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1573-2606
          Numbering:
            – Type: volume
              Value: 26
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Reviews in endocrine & metabolic disorders
              Type: main
ResultId 1